Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography
REPEATCPETecho
Analysing the Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography
1 other identifier
interventional
30
1 country
1
Brief Summary
CPETecho is progressively employed in diagnostic settings for pathophysiological detection, offering comprehensive assessment of both pulmonary and cardiac functions. This technique evolves from its invasive counterpart, where a diagnostic catheter is employed for hemodynamic monitoring, by substituting the invasive component with non-invasive echocardiography. Nevertheless, data on the test-retest reliability of CPETecho remain sparse, a factor critical in differentiating between measurement effects and actual therapeutic impacts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2024
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedDecember 15, 2025
November 1, 2025
4 months
February 26, 2024
December 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation coefficient (ICC)
Analysing the Test-Retest Reliability of Cardiopulmonary Exercise Testing with Echocardiography
Up to 2 weeks
Study Arms (1)
Single arm
OTHERRepeat CPET echo with a one-week interval
Interventions
Eligibility Criteria
You may qualify if:
- Capable of performing a maximal exercise test.
- Provide signed and dated informed consent.
You may not qualify if:
- \- Unstable symptoms, whereby therapy cannot be delayed for a week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ziekenhuis Oost-Limburg
Genk, 3600, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2024
First Posted
December 15, 2025
Study Start
November 1, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
December 15, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share